These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 23382889

  • 41. Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population.
    García Rodríguez LA, Varas-Lorenzo C, Maguire A, González-Pérez A.
    Circulation; 2004 Jun 22; 109(24):3000-6. PubMed ID: 15197149
    [Abstract] [Full Text] [Related]

  • 42. Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs.
    Mamdani M, Rochon PA, Juurlink DN, Kopp A, Anderson GM, Naglie G, Austin PC, Laupacis A.
    BMJ; 2002 Sep 21; 325(7365):624. PubMed ID: 12242172
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. New-onset atrial fibrillation is associated with cardiovascular events leading to death in a first time myocardial infarction population of 89,703 patients with long-term follow-up: a nationwide study.
    Bang CN, Gislason GH, Greve AM, Bang CA, Lilja A, Torp-Pedersen C, Andersen PK, Køber L, Devereux RB, Wachtell K.
    J Am Heart Assoc; 2014 Jan 21; 3(1):e000382. PubMed ID: 24449803
    [Abstract] [Full Text] [Related]

  • 45. Factors associated with celecoxib and rofecoxib utilization.
    Rawson NS, Nourjah P, Grosser SC, Graham DJ.
    Ann Pharmacother; 2005 Apr 21; 39(4):597-602. PubMed ID: 15755796
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Risk of acute myocardial infarction during use of individual NSAIDs: A nested case-control study from the SOS project.
    Masclee GMC, Straatman H, Arfè A, Castellsague J, Garbe E, Herings R, Kollhorst B, Lucchi S, Perez-Gutthann S, Romio S, Schade R, Schink T, Schuemie MJ, Scotti L, Varas-Lorenzo C, Valkhoff VE, Villa M, Sturkenboom MCJM.
    PLoS One; 2018 Apr 21; 13(11):e0204746. PubMed ID: 30383755
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Cardiovascular safety of using non-steroidal anti-inflammatory drugs for gout: a Danish nationwide case-crossover study.
    Bech-Drewes A, Bonnesen K, Hauge EM, Schmidt M.
    Rheumatol Int; 2024 Jun 21; 44(6):1061-1069. PubMed ID: 38581450
    [Abstract] [Full Text] [Related]

  • 52. Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study.
    Mamdani M, Juurlink DN, Lee DS, Rochon PA, Kopp A, Naglie G, Austin PC, Laupacis A, Stukel TA.
    Lancet; 2004 May 29; 363(9423):1751-6. PubMed ID: 15172772
    [Abstract] [Full Text] [Related]

  • 53. Diclofenac use and cardiovascular risks: series of nationwide cohort studies.
    Schmidt M, Sørensen HT, Pedersen L.
    BMJ; 2018 Sep 04; 362():k3426. PubMed ID: 30181258
    [Abstract] [Full Text] [Related]

  • 54. [Gastrointestinal complications under NSAID treatment in the doctor's office].
    Hollenz M, Labenz J.
    MMW Fortschr Med; 2004 Dec 02; 146(49):42, 44. PubMed ID: 15646716
    [Abstract] [Full Text] [Related]

  • 55. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.
    Chen YF, Jobanputra P, Barton P, Bryan S, Fry-Smith A, Harris G, Taylor RS.
    Health Technol Assess; 2008 Apr 02; 12(11):1-278, iii. PubMed ID: 18405470
    [Abstract] [Full Text] [Related]

  • 56. Safety of nonsteroidal anti-inflammatory drugs in patients with cardiovascular risk.
    Naumov AV, Tkacheva ON, Khovasova NO.
    Ter Arkh; 2019 Mar 11; 91(1):108-113. PubMed ID: 31090381
    [Abstract] [Full Text] [Related]

  • 57. Cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs and the risk of ischemic stroke: a nested case-control study.
    Andersohn F, Schade R, Suissa S, Garbe E.
    Stroke; 2006 Jul 11; 37(7):1725-30. PubMed ID: 16728684
    [Abstract] [Full Text] [Related]

  • 58. Nonsteroidal antiinflammatory drug use and cardiovascular risks after coronary stent implantation.
    Schmidt M, Pedersen L, Maeng M, Lassen JF, Lash TL, Nielsen TT, Sørensen HT.
    Pharmacotherapy; 2011 May 11; 31(5):458-68. PubMed ID: 21923427
    [Abstract] [Full Text] [Related]

  • 59. Cardiovascular and Bleeding Risks Associated With Nonsteroidal Anti-Inflammatory Drugs After Myocardial Infarction.
    Kang DO, An H, Park GU, Yum Y, Park EJ, Park Y, Jang WY, Kim W, Choi JY, Roh SY, Na JO, Kim JW, Kim EJ, Rha SW, Park CG, Seo HS, Choi CU.
    J Am Coll Cardiol; 2020 Aug 04; 76(5):518-529. PubMed ID: 32731930
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.